ArticleCureus2026
Never Say Never: Presumed Inherited Factor VII Deficiency Lies in Wait for 17 Years.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A previously healthy, 17-year-old girl presented with gross hematuria in the setting of a severely deranged coagulation profile: prothrombin time (PT) > 320 s, international normalized ratio (INR) 15, and activated partial thromboplastin time (aPTT) 59 s. Factor VII (F7) activity (FVII:C) was undetectable. Following administration of two units of fresh frozen plasma (FFP) and phytonadione, her FVII:C increased to 38%, and coagulation profile improved to PT 16.0 s, INR 1.4, and aPTT 30.3 s. With the near-total loss of such a critical coagulation factor, we felt it was exceedingly unusual for a patient to present after 17 years without antecedent bleeding. However, testing ruled out inhibitors, which strongly suggested her deficiency was inherited as opposed to acquired. Moreover, we would not anticipate such dramatic rescue of the coagulation profile with FFP if inhibitors were present, even if they were cross-reactive with F7 and another coagulation factor. And with a vitamin K level near the lower limit of normal, we surmised that a vitamin K insufficiency complicated her severe factor deficiency. As such, while uncommon, patients with severe, inherited deficiency of F7 may not experience their index bleed until many years, even decades, after infancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.